The FDA in January asked Amgen to pull Tavneos from the market, citing liver toxicity issues that affected the drug’s overall ...

The FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to ...

Amgen (AMGN) ended the recent trading session at $347.94, demonstrating a -1.51% change from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.11%. On the other hand, ...

Zai Lab (ZLAB) stock jumps as the company announces a global clinical trial collaboration with Amgen (AMGN). Read more here.

Amgen’s rare disease drug Tavneos is under mounting regulatory scrutiny, with the FDA warning of serious liver injuries, ...

Amgen drug under FDA review Tavneos is linked to 76 liver injury cases including eight deaths; FDA advises liver monitoring ...

The Irish arm of bio-pharmaceutical giant Amgen has invested $407m (€353.3m) on capital expenditure on its Dun Laoghaire ...

By Puyaan Singh March 31 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it has identified cases of liver ...

Zai Lab and Amgen will collaborate on a clinical trial to evaluate a Zai Lab lung cancer therapy. Under the agreement, Amgen will sponsor a global phase 1b study to evaluate the safety and efficacy of ...

Dividend payers might become more popular if the recent volatility continues. These two stocks are great picks to weather the ...

The FDA has ramped up the pressure on Amgen to withdraw Tavneos for a rare vasculitis condition from the market, with a ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit ...